| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/14/2002 | CA2419726A1 Preparations for diagnosing extrapancreatic secretory function |
| 03/13/2002 | EP1186305A1 New brominated compounds as contrast media for X-ray mammography |
| 03/13/2002 | EP1185651A2 Test animal for atherosclerosis model and methods for testing and screening |
| 03/13/2002 | EP1185526A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 03/13/2002 | EP1185309A1 Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 03/13/2002 | EP1185308A2 Glp-1 as a diagnostic test to determine beta-cell function |
| 03/13/2002 | EP1185307A2 Methods of imaging and targeting tumor vasculature |
| 03/13/2002 | EP1185298A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185223A1 Methods for delivering in vivo uniform dispersed embolic compositions of high viscosity |
| 03/13/2002 | EP0930844A4 Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent |
| 03/13/2002 | CN1340042A Preparation of iodixanol |
| 03/12/2002 | US6356782 Subcutaneous cavity marking device and method |
| 03/12/2002 | US6355613 Cyclized oligopeptides with bridging groups of amide, thioether, thioester or disulfide |
| 03/12/2002 | US6355451 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 03/12/2002 | US6355411 Virulence-associated nucleic acid sequences and uses thereof |
| 03/12/2002 | US6355225 Fullerene contrast agent for magnetic resonance imaging and spectroscopy |
| 03/12/2002 | US6355224 Magnetic resonance imaging |
| 03/12/2002 | CA2262550C Apparatus and method for marking tissue |
| 03/12/2002 | CA2086438C Anti-herpes virus and cytomegalovirus oligomers |
| 03/12/2002 | CA2016235C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 03/07/2002 | WO2002018620A2 Neutrokine-alpha and neutrokine-alpha splice variant |
| 03/07/2002 | WO2002018576A2 Compositions and methods relating to lung specific genes |
| 03/07/2002 | WO2002018450A1 New cross-linked derivatives of hyaluronic acid |
| 03/07/2002 | WO2002017891A2 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 03/07/2002 | WO2001042220A3 Podate ligands and methods of use thereof |
| 03/07/2002 | WO2001024831A3 Polymer stabilized neuropeptides |
| 03/07/2002 | WO2000073344A9 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/07/2002 | US20020028993 Having carboxylate, amine and multidentate thiol containing ligands; magnetic resonance imaging of tissue |
| 03/07/2002 | US20020028514 Recombinant AAV vector-based transduction system and use of same |
| 03/07/2002 | US20020028217 Microparticle preparations made of biodegradable copolymers |
| 03/07/2002 | US20020028179 Fluorocarbon gas osmotic agent dispersed in spray dried microspheres comprising a surfactant with starch, derivatized starch, dextrin, or sugar esters having a component with a hydrophilic/lipophilic balance of less than 8 |
| 03/07/2002 | DE10040052A1 Verwendung von Protonenpumpen-Hemmern zur Behandlung von Entzündungen, insbesondere von Erkrankungen des Bewegungsapparates Use of proton pump inhibitors for the treatment of inflammation, especially of disorders of the musculoskeletal system |
| 03/07/2002 | CA2419661A1 Neutrokine-alpha and neutrokine-alpha splice variant |
| 03/06/2002 | EP1184377A1 Hepatobiliary magnetic resonance contrast agents |
| 03/06/2002 | EP1183255A1 Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 03/06/2002 | EP1183050A2 Method for producing an injectable medicament preparation |
| 03/06/2002 | EP1017425A4 Improved methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator |
| 03/06/2002 | EP0767621B1 Implantable capsule for enhancing cell electric signals |
| 03/06/2002 | CN1338312A Aerogenic tablet for gastrointestinal contrast |
| 03/06/2002 | CN1080126C X-ray contrast medium used for checking of large and small intestine |
| 03/05/2002 | US6353151 Transgenic model for heart failure |
| 03/05/2002 | US6352828 Oligonucleotide tags for sorting and identification |
| 03/05/2002 | US6352683 Apparatus and method for the local delivery of drugs |
| 02/28/2002 | WO2002016939A2 Methods of diagnosis of cancer and screening for cancer modulators |
| 02/28/2002 | WO2002016933A1 Method and device for determining state of skin surface |
| 02/28/2002 | WO2002016333A2 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 02/28/2002 | WO2002015881A2 Use of a porous carrier |
| 02/28/2002 | WO2001072281A3 Microspheres for active embolization |
| 02/28/2002 | WO2001065998A3 Methods for the diagnosis and treatment of breast cancer |
| 02/28/2002 | US20020026649 Metastasis models using green fluorescent protein (GFP) as a marker |
| 02/28/2002 | US20020026648 Function-based small molecular weight compound screening system in drosophila melanogaster |
| 02/28/2002 | US20020026117 Instrument having enhanced ultrasound visibility |
| 02/28/2002 | US20020025298 Use of texaphyrin in ocular diagnosis and therapy |
| 02/28/2002 | US20020025297 Methods of screening agents for activity using teleosts |
| 02/28/2002 | US20020025296 Selecting foreign gene which has been isolated from a cell or virus and which has been transferred into the cells; selecting a labelled compound which will interact selectively with a protein; administering to the cells an effective dose |
| 02/28/2002 | DE10040380A1 MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties |
| 02/28/2002 | CA2420194A1 Use of a porous carrier |
| 02/27/2002 | EP1181940A2 In vivo diagnostics by near infrared radiation |
| 02/27/2002 | EP1181939A1 Method for evaluating matrix metalloprotease inhibitory activity |
| 02/27/2002 | EP1181933A2 Use of growth hormone secretagogues for stimulating or increasing appetite |
| 02/27/2002 | EP1181571A1 Method of magnetic resonance imaging |
| 02/27/2002 | EP1181352A1 Versican and epithelial-mesenchymal interaction |
| 02/27/2002 | EP1181318A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 02/27/2002 | EP1181033A1 Use of a pharmacological agent in the diagnosis of obsessive-compulsive disorder |
| 02/27/2002 | EP1180938A2 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 02/27/2002 | CN1337885A Hyperpolarized helius-3 microbubble gas entrapment methods |
| 02/27/2002 | CN1079679C Cascade polymer complexes, its preparation process and medicine containing said complexes |
| 02/27/2002 | CN1079678C Long-lasting aqueous dispersions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 02/27/2002 | CN1079642C Novel embolizing compositions |
| 02/26/2002 | US6351663 Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation |
| 02/26/2002 | US6350466 Targeted polymerized liposome diagnostic and treatment agents |
| 02/26/2002 | US6350431 Light image contrast agent with chromopores linked with polyether |
| 02/26/2002 | CA2081605C Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002013876A2 Tissue marking using biocompatible microparticles |
| 02/21/2002 | WO2002013875A2 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 02/21/2002 | WO2002013796A2 Use of proton pump inhibitors for treating diseases of the locomotor system |
| 02/21/2002 | WO2001060820A3 Matrix metalloproteinase inhibitors and uses thereof |
| 02/21/2002 | WO2001047510A3 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 02/21/2002 | WO2001030967A3 Fluorescent cobalamins and uses thereof |
| 02/21/2002 | US20020022781 Products and methods for brachytherapy |
| 02/21/2002 | US20020022658 Methods for selectively occluding blood supplies to neoplasias |
| 02/21/2002 | US20020022235 Monitoring immunotherapeutic activities; measure antibody concentration of human, incubate human with xenogenic antibody, monitor concentration of antibodies, amplified levels of antibodies indicates effective therapy |
| 02/21/2002 | US20020022004 Contrast medium for near infrared diagnosis |
| 02/21/2002 | US20020022003 Method and composition for the treatment of cancer by the enzymantic conversion of soluble radioactive toxic precipitates in the cancer |
| 02/21/2002 | DE10111224A1 Analoge der Ecstasy-Klasse sowie Verwendung derselben beim Nachweis von Verbindungen der Ecstasy-Klasse Analog ecstasy-class and use thereof in the detection of compounds of ecstasy-class |
| 02/21/2002 | CA2419259A1 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 02/20/2002 | EP1180051A1 Methods for embolizing vascular sites with an embolizing composition |
| 02/20/2002 | EP1180043A1 Multi-stage method for producing gas-filled microcapsules |
| 02/20/2002 | EP0728215B1 METHOD OF BINDING MATERIAL TO THE Beta-AMYLOID PEPTIDE |
| 02/20/2002 | CN1336237A Low-density gastrointestinal contrast medium and its production process |
| 02/20/2002 | CN1079266C Contrast agents and its improvement |
| 02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
| 02/19/2002 | US6348214 Materials and methods for making improved liposome compositions |
| 02/19/2002 | US6348186 Preparation of further diagnostic agents |
| 02/19/2002 | US6348185 Functional moiety linking peptide to diagnostic or pharmaceutically active substance and which confers target cell specificity to said compound; radiotherapy and drug delivery; conjugate coordination and covalent complexes; |
| 02/14/2002 | WO2002012539A2 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |